IU Scientists Map Breast Cells to Explore Cancer Origins and Genetic Ancestry Impact

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have completed the most extensive mapping of healthy breast cells to date. These findings offer an important tool for researchers at IU and beyond to understand how breast cancer develops and the differences in breast tissue among genetic ancestries.

Published this month in Nature Medicine, researchers developed a comprehensive atlas of breast tissue cells – including details on how genome is organized in each cell type and the effects of this genome organization on how RNA is made in each cell type to drive their function in various parts of the breast – using healthy breast tissue from women of diverse ancestry.

Breast cancer shows variability in the outcome based on your genetic ancestry. While socio-economics are certainly a contributing factor, we believe biology and ancestry also play a role. This study will help us to address that biological, ancestral aspect."

Harikrishna Nakshatri, PhD, senior author of the study

Nakshatri is the Marian J. Morrison Professor of Breast Cancer Research at IU School of Medicine and a researcher of the Vera Bradley Foundation Center for Breast Cancer Research at the IU Simon Comprehensive Cancer Center.

Nakshatri's lab sequenced 88,000 cell nuclei from 92 women who donated healthy breast tissue to the Komen Tissue Bank at the IU Simon Comprehensive Cancer Center. The donors included people of African, European, Indigenous American, Hispanic, East Asian, Southeast Asian and Ashkenazi-Jewish-European ancestry.

The cell mapping includes data not only on the genes expressed in various cell types, but also on how the genes are organized and what specific gene expressions are limited to each cell type. Researchers know breast cancer most often originates in specific cell types and where it originates leads to different cancer type and treatment responses. This study could improve understanding of breast cancer development and lead to identifying new treatment targets.

"This research aimed to understand the building blocks of the normal breast – meaning how many different cell types exist in the normal breast and do the building blocks of the cells show genetic ancestry-dependent variability," Nakshatri said. "Unless we know from which cell types of the breast the cancer originates, we can't really figure out what exactly is going wrong in breast cancer compared to the normal breast."

Previously available research resources have used normal tissue from breast cancer surgeries and reduction mammoplasty samples. The Komen Tissue Bank, the world's only healthy breast tissue bank, offers IU researchers a unique opportunity for this study.

"We are using tissue from women who are clinically free of breast cancer; for that reason, we do believe the data that we created are close to perfect-;truly the closest you can get," Nakshatri said. "The data we generated from this is going to stay in perpetuity because it's going to be used by many, many groups for future research."

The cell atlas information from the study will be broadly available to breast cancer researchers through databases offered by the National Institutes of Health, Human Cell Atlas and Chan Zuckerberg CELL by GENE Discover.

This research is the culmination of nearly five years of intense work from the Nakshatri lab and with bioinformatic analysis. Additional IU School of Medicine and IU Simon Comprehensive Cancer Center authors include Poornima Bhat-Nakshatri, Hongyu Gao, Aditi S. Khatpe, Adedeji K. Adebayo, Patrick C. McGuire, Cihat Erdogan, Duojiao Chen, Guanglong Jiang, Rana German, Lydia Emmert, George Sandusky, Anna Maria Storniolo and Yunlong Liu.

Source:
Journal reference:

Bhat-Nakshatri, P., et al. (2024). Single-nucleus chromatin accessibility and transcriptomic map of breast tissues of women of diverse genetic ancestry. Nature Medicine. doi.org/10.1038/s41591-024-03011-9.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.